Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.

Biopharma money raised to-date and by month in 2026, including public, private and other financings.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alvotech, Amneal, Attralus, Biogen, GE, Innovent, Iovance, Kashiv, Lupeng, Mammotome, Pharming, Quoin, Verastem, Xbrane, Zepto.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Cytodyn, Everest, Lonza, Mabworks, Massive, Mira, Miralogx, Mobil Saúde Comercial, Natera, Optellum, Stipple, Tempramed, Teva.

Clinical updates for biopharma and med tech, including data readouts and publications: ADC, AN2, Aurinia, Autobahn, Biogen, Fate, Fractyl, GH, Immutep, Innovent, Juncell, Kallyope, Novartis, Novartis, Spectral, Taiho, UCB, Vantive.

Biopharma and med-tech companies raising money in public or private financings, including: Artan, Celcuity, Cerevasc, Imunon, Jade, Olix, Parabilis.

New hires and promotions in the biopharma and med-tech industries, including: Alera, Beyondspring, Quanterix.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Coloplast, Cycle, Hopstem, Orthalign, QT, Reach, Royal, Sotio, Terremoto, Waters, Xenix.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Abbott, Alnylam, Alpha Tau, Astrazeneca, Axsome, Daiichi, Inceptive, Leica, Minimed, Nanodetection, Oligomerix Tolmar.